Flubromazepam

Flubromazepam

Clinical data
Routes of administration	Oral
Legal status
Legal status	CA: Schedule IV DE: Anlage II (Prohibited)
Pharmacokinetic data
Biological half-life	106 hours
Identifiers
IUPAC name 7-Bromo-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one
CAS Number	2647-50-9 Y
PubChem (CID)	12947024
ChemSpider	10441497
UNII	GKX573279U Y
Chemical and physical data
Formula	C15H10BrFN2O
Molar mass	333.16 g/mol
3D model (Jmol)	Interactive image
SMILES BrC1=CC(C(C2=CC=CC=C2F)=NC3)=C(C=C1)NC3=O
InChI InChI=1S/C15H10BrFN2O/c16-9-5-6-13-11(7-9)15(18-8-14(20)19-13)10-3-1-2-4-12(10)17/h1-7H,8H2,(H,19,20) Key:ZRKDDZBVSZLOFS-UHFFFAOYSA-N

Flubromazepam is a benzodiazepine derivative which was first synthesized in 1960,^[1] but was never marketed and did not receive any further attention or study until late 2012 when it appeared on the grey market as a novel designer drug.^{[2][3][4][5][6][7]}

It is a structural analog of phenazepam in which the chlorine atom has been replaced by a fluorine atom.

An alternate isomer, 5-(2-bromophenyl)-7-fluoro-1,3-dihydro-2H-1,4-benzodiazepin-2-one, may have been sold under the same name.^[2]

Alternate isomer

See also

References